Studies have shown that the PI3K/AKT/mTOR pathway is crucial in a variety of inflammatory diseases such as chronic obstructive pulmonary disease (COPD), inflammatory bowel disease (IBD), multiple sclerosis (MS), and systemic lupus erythematosus (SLE), etc. [16,17,18]. Here, AKT1 is linked to systemic lupus erythematosus.